These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35571641)

  • 1. The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy-rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial.
    Begum H; Swaminath A; Lee Y; Fahim C; Bramson J; Naqvi A; Shargall Y; Finley C; Hanna W; Agzarian J
    Transl Cancer Res; 2022 Apr; 11(4):918-927. PubMed ID: 35571641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases.
    Lee YH; Kang KM; Choi HS; Ha IB; Jeong H; Song JH; Jang IS; Kim SH; Lee JW; Rhee DY; Jeong BK
    Thorac Cancer; 2018 Dec; 9(12):1671-1679. PubMed ID: 30298701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors.
    Kanzaki R; Suzuki O; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Tamari K; Otani K; Seo Y; Isohashi F; Ogawa K; Okumura M
    J Cardiothorac Surg; 2020 Feb; 15(1):43. PubMed ID: 32103767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
    Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
    BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study.
    Dong B; Chen R; Zhu X; Wu Q; Jin J; Wang W; Zhu Y; Jiang H; Bi N; Wang X; Xu X; Xu Y; Chen M
    Clin Transl Radiat Oncol; 2023 May; 40():100601. PubMed ID: 36936471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy.
    Meacci E; Nachira D; Congedo MT; Ibrahim M; Pariscenti G; Petrella F; Casiraghi M; De Stefani A; Del Regno L; Peris K; Triumbari EKA; Schinzari G; Rossi E; Petracca-Ciavarella L; Vita ML; Chiappetta M; Siciliani A; Peritore V; Manitto M; Morelli L; Zanfrini E; Tabacco D; Calabrese G; Bardoni C; Evangelista J; Spaggiari L; Margaritora S
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
    Paiella S; Malleo G; Simoni N; Micera R; Guariglia S; Cavedon C; Marchegiani G; Esposito A; Landoni L; Casetti L; Tuveri M; Milella M; Secchettin E; Manzini G; Bovo C; De Pastena M; Fontana M; Salvia R; Mazzarotto R; Bassi C
    BMC Cancer; 2021 Feb; 21(1):165. PubMed ID: 33593311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer.
    Singh AK; Hennon M; Ma SJ; Demmy TL; Picone A; Dexter EU; Nwogu C; Attwood K; Tan W; Hermann GM; Fung-Kee-Fung S; Malhotra HK; Yendamuri S; Gomez-Suescun JA
    BMC Cancer; 2018 Nov; 18(1):1183. PubMed ID: 30497431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.
    Hattori N; Kanemitsu Y; Komori K; Shimizu Y; Sano T; Senda Y; Mitsudomi T; Fukui T
    World J Surg; 2013 Jun; 37(6):1315-21. PubMed ID: 23435701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
    Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
    Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.
    Wada Y; Hashimoto M
    Transl Cancer Res; 2020 Aug; 9(8):5077-5086. PubMed ID: 35117873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.
    Al-Batran SE; Homann N; Pauligk C; Illerhaus G; Martens UM; Stoehlmacher J; Schmalenberg H; Luley KB; Prasnikar N; Egger M; Probst S; Messmann H; Moehler M; Fischbach W; Hartmann JT; Mayer F; Höffkes HG; Koenigsmann M; Arnold D; Kraus TW; Grimm K; Berkhoff S; Post S; Jäger E; Bechstein W; Ronellenfitsch U; Mönig S; Hofheinz RD
    JAMA Oncol; 2017 Sep; 3(9):1237-1244. PubMed ID: 28448662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
    BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
    Sundahl N; De Wolf K; Rottey S; Decaestecker K; De Maeseneer D; Meireson A; Goetghebeur E; Fonteyne V; Verbeke S; De Visschere P; Reynders D; Van Gele M; Brochez L; Ost P
    J Transl Med; 2017 Jun; 15(1):150. PubMed ID: 28662677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer.
    Zakem SJ; Mueller AC; Meguid C; Torphy RJ; Holt DE; Schefter T; Messersmith WA; McCarter MD; Del Chiaro M; Schulick RD; Goodman KA
    HPB (Oxford); 2021 Jul; 23(7):1072-1083. PubMed ID: 33277184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.
    Chapman BC; Gleisner A; Rigg D; Meguid C; Goodman K; Brauer B; Gajdos C; Schulick RD; Edil BH; McCarter MD
    J Surg Oncol; 2018 Apr; 117(5):1073-1083. PubMed ID: 29448308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases?
    Li S; Nie S; Li Z; Che G
    Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):544-550. PubMed ID: 31180484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
    Front Oncol; 2021; 11():728519. PubMed ID: 34912703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.